Carregant...
Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers
PURPOSE: (18)F-fluorodeoxyglucose positron emission tomopraphy/computed tomography (FDGPET/CT) has been proven to be useful for imaging many types of cancer; however, its role is not well defined in hepatocellular carcinoma (HCC). We assessed the prognostic value of metabolic imaging biomarkers as e...
Guardat en:
| Publicat a: | Eur J Nucl Med Mol Imaging |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5400685/ https://ncbi.nlm.nih.gov/pubmed/27942837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-016-3583-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|